技术指标
指标
数值
方向
MACD(12,26,9)
-0.008
卖出
RSI(14)
32.675
中性
STOCH(KDJ)(9,3,3)
12.703
超卖
ATR(14)
0.033
低波动
CCI(14)
-88.385
中性
Williams %R
82.860
超卖
TRIX(12,20)
-0.658
卖出
StochRSI(14)
100.000
买入
搜索
Oragenics Inc
OGEN添加自选
0.505USD
+0.015+3.02%
收盘 07-31 16:00（美东）报价延迟15分钟
2.16M总市值
亏损市盈率 TTM
关键数据
0.487今开
0.510最高
41.56K成交量
亏损市盈率 TTM
亏损市盈率动
--股息TTM
0.97%换手率
0.490昨收
0.487最低
13.51K成交额
亏损市盈率静
0.26市净率
0.00%股息率 TTM
-173.03%ROA
9.60052周最高
2.59量比
-10.57M净利润
4.27M总股本
-1.4237每股收益TTM
1.27Beta
-311.00%ROE
0.50452周最低
4.65%振幅
100.00%毛利率
2.16M总市值
-3.46回报/风险
4.69%风险率
TradingKey Oragenics Inc股票评分
单位: USD 更新时间: 2026-07-31操作建议
Oragenics Inc当前公司基本面数据相对非常健康，增长潜力很大。当前估值合理，在生物技术与医疗研究行业排名194/385位。机构持股占比非常高，近一月多位分析师给出公司评级为。最高目标价2.00。中期看，股价处于下降通道。近一个月，市场表现较差，但基本面评分较高。目前股价在压力位和支撑位之间，可以做区间波段操作。
Oragenics Inc评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
公司舆情
过去24小时
热度
过冷
过热
中性
Oragenics Inc亮点
亮点风险
Oragenics, Inc. is a development-stage company. It is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. It focuses on nasal delivery of pharmaceutical medications in neurology and fighting infectious diseases, including drug candidates for treating mild traumatic brain injury (mTBI or Concussion), and for treating Niemann Pick Disease Type C (NPC), and proprietary powder formulation and an intranasal delivery device. Its lead product, ONP-002, is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. It is also focused on developing medical products that treat brain related illnesses and diseases (the Neurology Assets). Its other product candidate, ONP-001, is in its early stage and clinical trials.
估值低估
公司最新PE估值-0.35，处于3年历史低位
机构加仓
最新机构持股353.35K股，环比增加30.85%
分析师目标
根据
0
位分析师
--
评级
2.000
目标均价
+302.66%
涨幅空间
Oragenics Inc新闻
即将为您带来更多新闻，敬请期待。。。
收益预测
分析师评级
根据
0
位分析师
--
评级
2.000
目标均价
+302.66%
涨幅空间
强力买入
买入
持有
卖出
强力卖出
同行比较
496
总数
6
中位数
7
平均值
公司名称
评级分布
分析师数
Oragenics Inc
OGEN
0
百济神州
ONC
27
argenx SE
ARGX
26
艾昆纬
IQV
26
Ionis Pharmaceuticals Inc
IONS
25
Insmed Inc
INSM
23
1
2
3
...
99
技术指标
移动平均线
指标
数值
方向
MA5
0.497
买入
MA10
0.511
卖出
MA20
0.541
卖出
MA50
0.574
卖出
MA100
0.614
卖出
MA200
0.776
卖出
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
Oragenics Inc简介
Oragenics, Inc. is a development-stage company. It is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. It focuses on nasal delivery of pharmaceutical medications in neurology and fighting infectious diseases, including drug candidates for treating mild traumatic brain injury (mTBI or Concussion), and for treating Niemann Pick Disease Type C (NPC), and proprietary powder formulation and an intranasal delivery device. Its lead product, ONP-002, is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. It is also focused on developing medical products that treat brain related illnesses and diseases (the Neurology Assets). Its other product candidate, ONP-001, is in its early stage and clinical trials.
公司代码OGEN
公司Oragenics Inc
CEOHuffman (Janet)
网址https://www.oragenics.com/
公司股东
相关品种
热门品种
常见问题
Oragenics Inc(OGEN)的当前股价是多少？
Oragenics Inc(OGEN)的当前股价是 0.51。
Oragenics Inc的股票代码是什么？
Oragenics Inc的股票代码是OGEN。
Oragenics Inc股票的52周最高点是多少？
Oragenics Inc股票的52周最高点是9.60。
Oragenics Inc股票的52周最低点是多少？
Oragenics Inc股票的52周最低点是0.50。
Oragenics Inc的市值是多少？
Oragenics Inc的市值是2.16M。
Oragenics Inc(OGEN)股票的每股收益（EPS TTM）是多少
Oragenics Inc(OGEN)股票的每股收益（EPS TTM）是-4.56。